Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,660 across all filing types
Latest filing 2024-12-04 Regulatory Filings
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Please find enclosed file.
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding an intimation under SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations 2015, specifically Regulations 30 and 30A. It includes detailed disclosures about a distribution agreement termination and a new distribution agreement between subsidiaries and related parties. The content focuses on regulatory compliance disclosures about agreements and related party transactions, not on financial results, management changes, or other report types. The document length is 8327 characters, which is substantial but the content is clearly an announcement of a regulatory disclosure under SEBI LODR, not a full financial or management report. Therefore, the document fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance disclosures that do not fit other specific categories.
2024-12-04 English
Others
Regulatory Filings Classification · 95% confidence The document is an intimation letter addressed to stock exchanges (NSE and BSE) under SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations 2015, specifically Regulations 30 and 30A. It discloses details about a distribution agreement termination and a new distribution agreement between subsidiaries and a third party. The content focuses on regulatory compliance disclosures about agreements and related party transactions, not on financial results, management changes, or other report types. The document is about disclosure of material events or agreements as required by stock exchange regulations. It is not a full financial report, earnings release, or management discussion. It is also not a proxy, AGM material, or legal proceeding. Given the nature of the disclosure and the regulatory references, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-04 English
Please find enclosed letter.
Board/Management Information Classification · 100% confidence The document is a formal disclosure submitted to stock exchanges (NSE and BSE) under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements. It announces a change in senior management personnel due to superannuation of Mr. Shantanu Tuli, President - Strategy and Brand Identity. The document includes details required by SEBI regulations and a brief annexure with specifics about the change. There is no financial data, earnings information, or report attached. The content clearly fits the category of announcing changes in senior management, which corresponds to Board/Management Information (MANG). The document length is short (3241 characters), and it is not an announcement of a report publication but a direct disclosure of management change.
2024-12-03 English
Change in Management
Board/Management Information Classification · 100% confidence The document is a formal disclosure submitted to stock exchanges (NSE and BSE) under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements, 2015. It announces a change in senior management personnel due to superannuation of Mr. Shantanu Tuli, President - Strategy and Brand Identity. The document includes details required by SEBI circulars about the change in management personnel. There are no financial statements, earnings data, or report attachments. The content clearly relates to management changes rather than financial results or other report types. Therefore, this document fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, confirming the classification.
2024-12-03 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release dated November 22, 2024, announcing that Morepen Laboratories Limited has earned an honor from the Asia Book of Records for promoting gut health awareness. It is addressed to stock exchanges for dissemination and contains no financial data, financial statements, or detailed report content. It is not an annual or interim report, earnings release, or any regulatory filing with substantive financial information. The document is informational and promotional in nature, describing a corporate achievement and product information. It fits the category of a general regulatory announcement or press release rather than a formal financial or governance filing. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2024-11-22 English
Please find enclosed press release.
Regulatory Filings Classification · 95% confidence The document is a press release dated November 22, 2024, announcing that Morepen Laboratories Limited has earned an honor from the Asia Book of Records for promoting gut health awareness. It is addressed to stock exchanges for dissemination and contains no financial data, financial statements, or detailed management discussion. It is not a report, audit, earnings release, or regulatory filing but a corporate announcement about a recognition event. The document is informational and promotional in nature, typical of a press release. Therefore, it does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement or miscellaneous filing that does not fit other categories.
2024-11-22 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.